The University of Iowa Hospitals and Clinics will be the first in the state to employ a Coralville company’s artificial intelligence diagnostics when scanning for diabetic retinopathy, the Cedar Rapids Gazette reports. The device, called IDx-DR and developed by IDx, received approval from the U.S. Food and Drug Administration in April. The technology takes images of a patient’s retina and analyzes the images to determine whether the retina has abnormalities symptomatic of diabetic retinopathy, a diabetes complication which may cause blindness if left untreated.